RESULT OF CT-GUIDED CORE NEEDLE BIOPSY FOR RETROPERITONEAL MASSES AT VIET DUC UNIVERSITY HOSPITAL

Minh Trí Đỗ1,, Đức Thiện Dư 2, Xuân Hải Đào 3, Văn Sỹ Thân 2, Nhật Anh Phan 1, Quang Lộc Trần 1, Mạnh Thường Lê1, Thanh Dũng Lê2
1 Hanoi medical university
2 Viet Duc hospital
3 Viet Duc hopsital

Main Article Content

Abstract

Objectives: To identify the effect and the value of CT-guided core needle biopsy for the pathological diagnosis of retroperitoneal masses. Methods: 31 patients were determined retroperitoneal masses by clinical examination, ultrasound and CT scanner, and these masses was taken CT-guided core needle biopsy by16- or 18G-semi-automatic biopsy guns, all of them have result of pathological diagnosis from March 2021 to July 2022 at Radiology Department, Viet Duc University Hospital. It is descriptive cross-sectional and prospective study. Results: All of patient’s specimens has been pathological diagnosed. In there, 24 cases get malignant masses, and 7 case get benign mases. 3 cases get mild complication as a small hematoma around the lesion after biopsy processing, 1 case get pain requiring analgesics. There aren’t any cases get serious complication which is needed blood transfusion or endovascular intervention for hemostasis. Conclusions: CT-guided core needle biopsy for retroperitoneal masses is safe, less invasive, effective, and high valuable method in diagnosing the retroperitoneal tumor’s pathology.

Article Details

References

1. Ahrar K, Javadi S. Biopsy Devices and Techniques. In: Ahrar K, Gupta S, eds. Percutaneous Image-Guided Biopsy. Springer New York; 2014:1-17. doi:10.1007/978-1-4614-8217-8_1
2. Clinical Value of CT-Guided Needle Biopsy for Retroperitoneal Lesions - PMC. Accessed August 27, 2022. https:// www.ncbi.nlm.nih.gov/pmc/articles/PMC3088852/
3. Das C, Sengupta M, Mukhopadhyay M, Saha AK. Critical clinical appraisal of the role of computed tomography-guided minimally invasive aspiration cytology in evaluation of retroperitoneal masses. Indian J Med Paediatr Oncol Off J Indian Soc Med Paediatr Oncol. 2014;35(1):60-65. doi:10.4103/0971-5851.133723
4. Chojniak R, Isberner RK, Viana LM, Yu LS, Aita AA, Soares FA. Computed tomography guided needle biopsy: experience from 1,300 procedures. Sao Paulo Med J Rev Paul Med. 2006;124(1):10-14. doi:10.1590/s1516-31802006000100003
5. An JY, Heo JS, Noh JH, et al. Primary malignant retroperitoneal tumors: Analysis of a single institutional experience. Eur J Surg Oncol EJSO. 2007;33(3):376-382. doi:10.1016/ j.ejso.2006.10.019
6. Schiavon LH de O, Tyng CJ, Travesso DJ, Rocha RD, Schiavon ACSA, Bitencourt AGV. Computed tomography-guided percutaneous biopsy of abdominal lesions: indications, techniques, results, and complications. Radiol Bras. 2018;51(3):141-146. doi:10.1590/0100-3984.2017.0045
7. Sainani NI, Arellano RS, Shyn PB, Gervais DA, Mueller PR, Silverman SG. The challenging image-guided abdominal mass biopsy: established and emerging techniques “if you can see it, you can biopsy it.” Abdom Imaging. 2013; 38(4):672-696. doi:10.1007/s00261-013-9980-0
8. Marcu RD, Diaconu CC, Constantin T, et al. Minimally invasive biopsy in retroperitoneal tumors. Exp Ther Med. 2019;18(6):5016-5020. doi:10.3892/etm.2019.8020